Clinical Nutrition
Clinical nutrition options for malnourished patients,
delivered with quality, precision and safety.
Visit our U.S. Catalog for all available Clinical Nutrition products, options and specifications, parts and accessories.
The Burden of Malnutrition in the U.S.
23%
23% of U.S. patients with malnutrition were readmitted to the hospital within 30 days of discharge, more than 50% higher than the rate among patients with no malnutrition.1
2 Million
Two million approximated hospital stays in the United States involve malnutrition.1
$49 Billion
In the United States in 2016, $49 billion in approximated hospital costs relate to malnutrition (12.6% of aggregate hospital costs).1
In the Hospital and at Home, We Support Safe and Personalized Nutritional Care
Proper clinical nutrition is an essential component for growth and development, patient recovery and health. Built on more than 70 years of therapeutic expertise, our comprehensive parenteral nutrition (PN) offering supports the diverse nutritional needs of your acute and chronic patients, including neonates, children and adults. From ready-to-use formulations to advanced compounding technology, we are innovating to expand the options for personalized nutritional care designed to optimize your patients’ health.
Three Steps to Clinical Nutrition Excellence
Are you empowered to customize nutrition?
ExactaMix Automated Compounder is the trusted name in compounding, preparing customized PN safely and efficiently. ExactaMix Pro is built on the same trusted system with new pro features, including advanced cybersecurity, a quad-core processor and redesigned display and hardware.
Rx Only: For safe and proper use of this device, please refer to Instructions for Use or User’s Manual.

Are you leveraging an extensive portfolio of PN solutions?
Baxter’s clinically proven IV macro and micronutrients deliver life-sustaining energy and nutrients, including amino acids, lipids, multivitamins and premix solutions.

Committed to Preventing Malnutrition
Baxter has partnered with organizations around the world, including the American Society for Parenteral and Enteral Nutrition and the European Society for Clinical Nutrition and Metabolism to advance awareness of the effects of malnutrition in U.S. healthcare systems and identify strategies to enhance patient care.
Clinical Nutrition Options for Malnourished Patients, Delivered with Quality, Precision and Safety
Baxter's product portfolio offers options for multi-chamber PN solutions with or without electrolytes or individual source solution containers, amino acids (protein), dextrose (carbohydrate) and IV fat emulsion (lipids), all suitable for compounding. We also provide pharmacy workflow management, labeling and compounding technology to support unique patient needs. This combination helps ensure options to appropriately prescribe nutritionally balanced PN therapy to meet your patients’ needs.

Access
We provide innovative and accessible products and services designed to be used in different healthcare environments, including in the ICU and the hospital, nursing homes, clinics and in homes.

Innovation
Our product portfolio contains many of the essential ingredients necessary to create well-balanced formulations of a clinical nutrition regimen. We also continue to invest in solutions and devices to help you more accurately measure your patients’ nutrition needs and provide individualized nutrition treatments.

Safety
Our formulations are manufactured to the highest standards for safety, and custom prescriptions can be prepared with consistent quality and safety using our leading pharmacy technology.
Clinical Support Solutions
Multi-Chamber Bag PN
Our multi-chamber bag PN formulations are designed to help reduce the burden on your pharmacy and nursing staff with a simplified preparation process and consistent quality. Additionally, research shows that premixes may help reduce the potential risk of medication errors and associated infections.1 Our multi-chamber bag PN formulations contain a balance of essential ingredients, including amino acids (protein), glucose (carbohydrates), IV fat emulsions (lipids) and electrolytes.
Compounded PN
Complex patient nutritional needs can require a customized parenteral solution. We are committed to providing the essential ingredients that help you formulate personalized PN solutions. Additionally, we are dedicated to providing advanced compounding technologies that help support your focus on formulation accuracy, pharmacy process efficiency and patient safety.

The Legacy of ExactaMix

1000+
hospital pharmacies and compounding centers use ExactaMix Automated Compounding System
30+
years of innovating parenteral nutrition (PN) compounding
>100M
bags compounded with ExactaMix Automated Compounding System
The Three Pillars of ExactaMix Pro Automated Compounder
- Accurate volumetric delivery with gravimetric check delivers transfer volumes as low as 0.2mL4
- Manual additions reminder to reduce ingredient omissions4
- Within formulary editor, set ingredients to active or inactive4
- Designed for seamless integration with order entry systems4
- Available in 12 and 24 ports4,5
- 4x the processing power as legacy ExactaMix4,6
- 15 months of data storage and ability to auto-schedule reports and export to Excel4
- Highly responsive, easy to clean touchscreen4
- Wi-Fi connectivity4
The first-and-only automated compounder certified to the FDA recognized UL 2900-2-1 cybersecurity standard
Home Nutritional Care
For many patients, the need for clinical nutrition therapy follows them home. Whether your patients need home parenteral nutrition due to intestinal failure, to prevent or treat malnutrition, or as supportive care, we are committed to helping ensure they get the nutrients needed—safely and effectively—with a wide range of formulations and educational resources.

Q-NRG+ Metabolic Monitor Indications for Use
The Q-NRG+ portable Metabolic Monitors are indicated for the measurement of Resting Energy Expenditure (REE) for spontaneously breathing and ventilated patients, within the following populations:
- Spontaneously breathing subjects > 33 lbs. (15 kg) when using a canopy
- Spontaneously breathing subjects age >six years and > 22 lbs. (10 kg) when using a face mask
- Ventilated subjects age >10 years and >22 lbs. (10 kg).
The Q-NRG+ Portable Metabolic Monitors are intended to be used in professional healthcare facilities only.
Warnings
This device measures clinical parameters used to aid diagnosis and it is intended only as an adjunct device in patient assessment. In case of disturbing conditions, the shutdown is allowed because the safety of the device towards patients and operators is not affected, since the final evaluation is performed on the outcome data measured during a complete test. No modification of this device is allowed.
Precautions/Contraindications
Carefully re-check ventilator functionality after connection of the parts. Make sure that the patients cuff pressure is high enough to avoid air leakage. Manipulation of the ventilator circuit may cause leaks that may lower alveolar ventilation. For more information please refer to User’s Manual.
References
- Barett ML, et al. Non-maternal and Non-neonatal Inpatient Stays in the United States Involving Malnutrition, 2016. ONLINE. August 30,2018. U.S. Agency for Healthcare Research and Quality.
- Oshima T, et al. Indirect calorimetry in nutritional therapy. A position paper by the ICALIC study group. Clin Nutr 2017;36:651-662.
- Q-NRG+ Portable Metabolic Monitor Operator’s Manual, April 2022.
- ExactaMix Pro 2400 Compounder Operator Manual. 0719006296 Rev. A, 2023-06-30.
- ExactaMix Pro 1200 Compounder Operator Manual. 0719006295 Rev. A, 2023-06-30
- ExactaMix 2400 Compounder Operator Manual. 5300-5164 Rev. A.
- Baxter. Data on File.
- CLINOLIPID (Lipid Injectable Emulsion) for intravenous use PI, 4/2024.
- SMOFLIPID® (lipid injectable emulsion), for intravenous use PI, 5/2023.
- INTRALIPID 20% (lipid injectable emulsion), for intravenous use PI, 5/2023.
- NUTRILIPID® 20% (lipid injectable emulsion), for intravenous use PI, 5/2023.
- Wanten GJA, Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007 May;85(5):1171-84. doi: 10.1093/ajcn/85.5.1171.
Disclaimers
Rx Only. For safe and proper use of products mentioned herein, please refer to the Operator’s Manual or Instructions for Use.
Baxter and Exactamix Pro are trademarks of Baxter International Inc. or its subsidiaries.
Q-NRG+ is a registered trademark of COSMED.

